0.0002USD
35.83 KUSD
3.92 MUSD
5.80 M
About AMEXDRUG CORPORATION
Sector
CEO
Jack N. Amin
Headquarters
Commerce
Website
Founded
2001
FIGI
BBG000JGX809
Amexdrug Corp. engages in the business of pharmaceutical, medical, and cosmeceutical industry. It operates through the Distribution and Health and Beauty Products segments. The Distribution segment consists of the wholesale and resale of brand and generic pharmaceutical products, over-the-counter drugs, and non-drug products. The Health and Beauty Products segment includes the manufacture and sale of cosmetic products. The company was founded in 2001 and is headquartered in Commerce, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AXRX is 0.0021 USD — it has increased by 5.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange AMEXDRUG CORPORATION stocks are traded under the ticker AXRX.
AXRX stock is 4.76% volatile and has beta coefficient of 5.79. Check out the list of the most volatile stocks — is AMEXDRUG CORPORATION there?
Yes, you can track AMEXDRUG CORPORATION financials in yearly and quarterly reports right on TradingView.
AXRX net income for the last quarter is 30.24 K USD, while the quarter before that showed −67.47 K USD of net income which accounts for 144.82% change. Track more AMEXDRUG CORPORATION financial stats to get the full picture.
No, AXRX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AXRX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMEXDRUG CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AMEXDRUG CORPORATION technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AMEXDRUG CORPORATION stock shows the sell signal. See more of AMEXDRUG CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AMEXDRUG CORPORATION EBITDA is 117.00 K USD, and current EBITDA margin is 2.99%. See more stats in AMEXDRUG CORPORATION financial statements.